Yphantides v. County of San Diego

District Court, S.D. California·Decided November 14, 2023·No. 3:21-cv-01575·Unknown

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 11 NICHOLAS YPHANTIDES, an Case No.: 21cv1575-GPC(BLM) individual, 12 ORDER GRANTING IN PART AND Plaintiff, 13 DENYING IN PART DEFENDANT’S v. MOTIONS IN LIMINE NOS. 1-6 AND 14 GRANTING IN PART AND COUNTY OF SAN DIEGO, a public 15 DENYING IN PART PLAINTIFF’S entity and DOES 1-10 inclusive, MOTION IN LIMINE NO. 2 16 Defendant. 17

18 A motion in limine hearing was held on November 6, 2023. (Dkt. No. 106.) Gregory 19 Klawitter and Aaron M. Olsen appeared on behalf of Plaintiff Dr. Nicholas Yphantides and 20 George Howard, Corrie Klekowski, and Frances Rogers appeared on behalf of Defendant 21 County of San Diego. After the hearing, both parties filed supplemental briefs on 22 Defendant’s motion in limine No. 4. (Dkt. Nos. 107, 108.) After reviewing the parties’ 23 briefs, supplemental briefs, supporting documents and hearing oral argument, the Court 24 GRANTS in part and DENIES in part Defendant’s motions in limine Nos. 1-6 and 25 GRANTS in part and DENIES in part Plaintiff’s motion in limine No. 2. 26 / / / 27 / / / 28 1 Discussion 2 A. Legal Standard on Motion in Limine 3 A party may use a motion in limine (“MIL”) to exclude inadmissible or prejudicial 4 evidence prior to trial. Luce v. United States, 469 U.S. 38, 40 n.2 (1984). “A motion in 5 limine is a procedural mechanism to limit in advance testimony or evidence in a particular 6 area.” United States v. Heller, 551 F.3d 1108, 1111 (9th Cir. 2009). “Although the Federal 7 Rules of Evidence do not explicitly authorize in limine rulings, the practice has developed 8 pursuant to the district court’s inherent authority to manage the course of trials.” Luce, 469 9 U.S. at 4 n.4; see also City of Pomona v. SQM N. Am. Corp., 866 F.3d 1060, 1070 (9th Cir. 10 2017) (motions in limine “are useful tools to resolve issues which would otherwise clutter 11 up the trial”) (citation omitted). “[A] ruling on a motion in limine is essentially a 12 preliminary opinion that falls entirely within the discretion of the district court. The district 13 court may change its ruling at trial because testimony may bring facts to the district court's 14 attention that it did not anticipate at the time of its initial ruling.” City of Pomona, 866 15 F.3d at 1070 (quoting United States v. Bensimon, 172 F.3d 1121, 1127 (9th Cir. 1999)). 16 B. Defendant’s MIL No. 1 to Preclude Evidence about County’s Response to 2017 17 Hepatitis A Outbreak 18 Defendant seeks to exclude any reference, evidence, testimony or comment by 19 counsel or witnesses concerning the County’s response to the outbreak of Hepatitis A 20 (“HepA”) in 2017, the County Grand Jury investigation of the outbreak or other 21 proceedings regarding the County’s response as irrelevant and meant to impugn the 22 competency of the County. (Dkt. No. 87.) County also argues that the evidence should be 23 excluded under Rule 403 as the evidence is prejudicial, will cause confusion of the issues 24 and will cause undue delay by requiring the County to engage in rebutting Plaintiff’s 25 evidence. (Id.) Plaintiff responds that the County misunderstands the purpose and 26 relevance of the evidence. (Dkt. No. 95.) As Chief Medical Officer (“CMO”), Plaintiff’s 27 job performance during and after the HepA outbreak, the county’s response, the Grand Jury 28 recommendations and the state audit are relevant to fully explain his state of mind, (stress, 1 anxiety), judgments, opinions and policies in responding to COVID-19 which are the 2 reasons he was terminated. (Id.) In responding to COVID-19, Plaintiff was afraid the 3 County would repeat the same mistakes of not responding fast enough as it had done in 4 responding to HepA. (Id.) The evidence is also relevant to show County’s reason for 5 terminating him based on “poor judgment” is not credible. (Id.) Finally, his ability to 6 perform his essential job duties despite his mental disability during HepA outbreak is 7 probative of his ability to perform those same duties during COVID-19. (Id.) 8 The Court DENIES Defendant’s MIL No. 1 as Plaintiff’s prior experience as CMO 9 during the HepA outbreak in 2017 is relevant to understanding or explaining, in part, how 10 Plaintiff’s mental disability evolved at the time COVID-19 pandemic began. However, 11 any extrinsic evidence such as the County Grand Jury investigation and report of May 2018 12 and the California State audit in December 2018 are inadmissible as it would cause delay 13 on issues not relevant, would be prejudicial and confuse the issues. Instead, Plaintiff will 14 be permitted to testify as to where he was at mentally and emotionally during the HepA 15 outbreak, whether the HepA experience contributed to his mental condition and whether 16 that experience was a contributing factor to his mental state during his handling of COVID- 17 19. 18 C. Defendant’s MIL No. 2 and Plaintiff’s MIL No. 2 Re: Attorney/Client 19 Privilege 20 Defendant County of San Diego moves to preclude any comment, suggestion or 21 reference to its assertion of the attorney-client privilege and the content as to any privileged 22 communication discussing Plaintiff’s termination between its executives, Dean Arabatzis, 23 the Acting Director of the County Health and Human Services Agency (“HHSA”), Helen 24 Robbins-Meyer, Brazeau, Chief Administrative Officer for the County, Nick Macchione1, 25 former Director of the County HHSA, and County Counsel, Bill Songer, during meetings 26 27 28 1 in December 2020 and January 2021 and in particular a meeting in March 2021 several 2 days before Plaintiff was terminated on March 22, 2021. (Dkt. No. 88.) It contends that 3 the jury could be left with the impression that the executives’ refusal to answer based on 4 the privilege is an improper effort to conceal or suppress evidence. (Id.) 5 Similarly, Plaintiff seeks to exclude evidence, testimony and arguments concerning 6 matters discussed in two March 2021 meetings where the County invoked the attorney- 7 client privilege, including any findings. (Dkt. No. 85.) Plaintiff’s MIL further seeks to 8 exclude ALL matters, even if discovered or disclosed outside the March 2021 meetings, 9 that were discussed at these meetings with County Counsel. (Id.) Plaintiff also moves to 10 bar any testimony or evidence about the occurrence of these privileged meetings as it would 11 suggest to the jury that the County’s decision to terminate Plaintiff was measured, thorough 12 and fair because top officials consulted with County Counsel.2 13 Contrary to the parties’ assertion, federal common law applies to the attorney-client 14 privilege in this federal question case. See Fed. R. Evid. 501; Stein v. Tri-City Healthcare 15 Dist., No. 12cv2524 BTM (BGS), 2013 WL 2417772 at *2 (S.D. Cal. June 3, 2013) 16 (“While ordinarily true, in cases where federal privilege law governs the claim over which 17 the Court has original subject matter jurisdiction, federal privilege law also applies to 18 supplemental state claims as well.”) (citing Religious Tech. Ctr. v. Wollersheim, 971 F.2d 19 364, 367 n. 10 (9th Cir. 1992)); Crowe v. Cnty. of San Diego, 242 F. Supp. 2d 740, 750 20 (S.D. Cal. 2003); see also Roberts v. Heim, 123 F.R.D. 614, 620-21 (N.D. Cal. 1988) 21 (reviewing cases holding federal common law of privileges governs all privilege issues in 22 federal question case with pendent state law claims)). California has a more “liberal view” 23 of the privilege that conflicts with the “strict view applied under federal law.” United 24 States v.

Free access — add to your briefcase to read the full text and ask questions with AI

Yphantides v. County of San Diego, (S.D. Cal. 2023).

Yphantides v. County of San Diego (Yphantides v. County of San Diego) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Luce v. United States
469 U.S. 38 (Supreme Court, 1984)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Hawn v. Executive Jet Management, Inc.
615 F.3d 1151 (Ninth Circuit, 2010)
Abbott Laboratories v. Mead Johnson & Company
971 F.2d 6 (Seventh Circuit, 1992)
Earl v. Nielsen Media Research, Inc.
658 F.3d 1108 (Ninth Circuit, 2011)
United States v. Gloria Ann Morales
108 F.3d 1031 (Ninth Circuit, 1997)
United States v. Guillermo Vallejo
237 F.3d 1008 (Ninth Circuit, 2001)
Carolyn Humphrey v. Memorial Hospitals Association
239 F.3d 1128 (Ninth Circuit, 2001)
United States v. Zebuel Jackson Hanna
293 F.3d 1080 (Ninth Circuit, 2002)
United States v. Ruehle
583 F.3d 600 (Ninth Circuit, 2009)
United States v. Heller
551 F.3d 1108 (Ninth Circuit, 2009)
United States v. Sensient Colors, Inc.
649 F. Supp. 2d 309 (D. New Jersey, 2009)
Gibbs v. American Airlines, Inc.
87 Cal. Rptr. 2d 554 (California Court of Appeal, 1999)
Morgan v. Regents of the University of California
105 Cal. Rptr. 2d 652 (California Court of Appeal, 2000)